{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:09:22Z","timestamp":1790881762720,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HEC Forum"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 1 diabetes (T1D) is a chronic illness that requires intensive lifelong management of blood glucose concentrations by means of external insulin administration. There have been substantial developments in the ways of measuring glucose levels, which is crucial to T1D self-management. Recently, continuous glucose monitoring (CGM) has allowed people with T1D to keep track of their blood\u00a0glucose levels in near real-time. These devices have alarms that warn users about potentially dangerous blood glucose trends, which can often\u00a0be shared with ther people. CGM is consistently associated with improved glycemic control and reduced hypoglycemia and is currently recommended by doctors. However, due to the costs of CGM, only those who qualify for hospital provision or those\u00a0who can personally afford it are able to use it, which excludes many people. In this paper, I argue that unequal access to CGM results in: (1) unjust health inequalities, (2) relational injustice, (3) injustice with regard to agency and autonomy, and (4) epistemic injustice. These considerations provide prima facie moral reasons why all people with T1D should have access to CGM technology. I discuss the specific case of CGM policy in the Netherlands, which currently\u00a0only provides coverage for a small group of people with T1D, and argue that, especially with additional considerations of cost-effectiveness, the Dutch government ought to include CGM in basic health care insurance for all\u00a0people with T1D.<\/jats:p>","DOI":"10.1007\/s10730-020-09413-9","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T05:02:41Z","timestamp":1590037361000},"page":"345-370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Continuous Glucose Monitoring as a Matter of Justice"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6338-6305","authenticated-orcid":false,"given":"Steven R.","family":"Kraaijeveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"issue":"2","key":"9413_CR1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.17925\/EE.2018.14.2.50","volume":"14","author":"P Adolfsson","year":"2018","unstructured":"Adolfsson, P., Rentoul, D., Klinkenbijl, B., & Parkin, C. G. (2018). Hypoglycaemia remains the key obstacle to optimal glycaemic control\u2014Continuous glucose monitoring is the solution. European Endocrinology, 14(2), 50\u201356.","journal-title":"European Endocrinology"},{"issue":"2","key":"9413_CR2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1086\/233897","volume":"109","author":"ES Anderson","year":"1999","unstructured":"Anderson, E. S. (1999). What's the point of equality? Ethics, 109(2), 287\u2013337.","journal-title":"Ethics"},{"issue":"3","key":"9413_CR3","first-page":"592","volume":"935","author":"SO Bakatselos","year":"2011","unstructured":"Bakatselos, S. O. (2011). Hypoglycemic unawareness. Diabetes Research and Clinical Practice, 935(3), 592\u2013596.","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"1","key":"9413_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6823-13-25","volume":"13","author":"M Balfe","year":"2013","unstructured":"Balfe, M., Doyle, F., Smith, D., Sreenan, S., Brugha, R., Hevey, D., et al. (2013). What's distressing about having type 1 diabetes? A qualitative study of young adults' perspectives. BMC Endocrine Disorders, 13(1), 1\u201314.","journal-title":"BMC Endocrine Disorders"},{"issue":"6","key":"9413_CR5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/bsl.513","volume":"20","author":"RC Baron","year":"2002","unstructured":"Baron, R. C., & Salzer, M. S. (2002). Accounting for unemployment among people with mental illness. Behavioral Sciences & The Law, 20(6), 585\u2013599.","journal-title":"Behavioral Sciences & The Law"},{"issue":"3","key":"9413_CR6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11019-016-9706-5","volume":"19","author":"RL Barreda","year":"2016","unstructured":"Barreda, R. L., Trachsel, M., & Bilndorno, N. (2016). Towards a broader understanding of agency in biomedical ethics. Medicine, Health Care and Philosophy, 19(3), 475\u2013483.","journal-title":"Medicine, Health Care and Philosophy"},{"key":"9413_CR7","volume-title":"Principles of biomedical ethics","author":"TL Beauchamp","year":"2013","unstructured":"Beauchamp, T. L., & Childress, J. F. (2013). Principles of biomedical ethics. New York: Oxford University Press."},{"issue":"8","key":"9413_CR8","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/dc09-0108","volume":"32","author":"Beck, R. W., & The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group","year":"2009","unstructured":"Beck, R. W., & The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2009). The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care, 32(8), 1378\u20131383.","journal-title":"Diabetes Care"},{"issue":"4","key":"9413_CR9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., et al. (2017). Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA, 317(4), 371\u2013378.","journal-title":"JAMA"},{"issue":"3","key":"9413_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2337\/diaclin.24.3.115","volume":"24","author":"VJ Briscoe","year":"2006","unstructured":"Briscoe, V. J., & Davis, S. N. (2006). Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clinical Diabetes, 24(3), 115\u2013121.","journal-title":"Clinical Diabetes"},{"issue":"5","key":"9413_CR11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jval.2011.02.001","volume":"14","author":"M Brod","year":"2011","unstructured":"Brod, M., Christensen, T., Thomsen, T. L., & Bushness, D. M. (2011). The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value in Health, 14(5), 665\u2013671.","journal-title":"Value in Health"},{"issue":"5","key":"9413_CR12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1258\/1357633042026251","volume":"10","author":"S Brownsell","year":"2004","unstructured":"Brownsell, S., & Hawley, M. (2004). Automatic fall detectors and the fear of falling. Journal of Telemedicine and Telecare, 10(5), 262\u2013267.","journal-title":"Journal of Telemedicine and Telecare"},{"key":"9413_CR13","unstructured":"Buss, S., & Westlund, A. (2018). Personal autonomy. In E. N. Zalta (Ed.), The Stanford encyclopedia of philosophy. https:\/\/plato.stanford.edu\/archives\/spr2018\/entries\/personal-autonomy. Accessed 16 May 2020."},{"issue":"4","key":"9413_CR14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11019-014-9560-2","volume":"17","author":"H Carel","year":"2014","unstructured":"Carel, H., & Kidd, I. J. (2014). Epistemic injustice in healthcare: A philosophical analysis. Medicine, Health Care and Philosophy, 17(4), 529\u2013540.","journal-title":"Medicine, Health Care and Philosophy"},{"key":"9413_CR15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4324\/9781315212043-33","volume-title":"The Routledge handbook of epistemic injustice","author":"H Carel","year":"2017","unstructured":"Carel, H., & Kidd, J. (2017). Epistemic injustice in medicine and healthcare. In P. Sullivan (Ed.), The Routledge handbook of epistemic injustice (pp. 336\u2013346). New York: Routledge."},{"issue":"3","key":"9413_CR16","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1210\/jc.2017-02498","volume":"103","author":"S Charleer","year":"2018","unstructured":"Charleer, S., Mathieu, C., Nobels, F., De Block, C., Radermecker, R. P., Hermans, M. P., et al. (2018). Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: A real-world study. Journal of Clinical Endocrinology & Metabolism, 103(3), 1224\u20131232.","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"11","key":"9413_CR17","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1080\/13696998.2017.1360312","volume":"20","author":"S Chaugule","year":"2017","unstructured":"Chaugule, S., & Graham, C. (2017). Cost-effectiveness of G5 mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective. Journal of Medical Economics, 20(11), 1128\u20131135.","journal-title":"Journal of Medical Economics"},{"key":"9413_CR18","unstructured":"Close, K., & Brown, A. (2017). CGM and time-in-range: What do diabetes experts think about goals?\" Diatribe.\u00a0https:\/\/diatribe.org\/cgm-and-time-range-what-do-diabetes-experts-think-about-goals. Accessed 16 May 2020."},{"issue":"5","key":"9413_CR19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2337\/diacare.10.5.617","volume":"10","author":"DJ Cox","year":"1987","unstructured":"Cox, D. J., Irvine, A., Gonder-Frederick, L., Nowacek, G., & Butterfield, J. (1987). Fear of hypoglycemia: Quantification, validation, and utilization. Diabetes Care, 10(5), 617\u2013621.","journal-title":"Diabetes Care"},{"issue":"9","key":"9413_CR20","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.2337\/dc12-0749","volume":"35","author":"PE Cryer","year":"2002","unstructured":"Cryer, P. E. (2002). Severe hypoglycemia predicts mortality in diabetes. Diabetes Care, 35(9), 1814\u20131816.","journal-title":"Diabetes Care"},{"issue":"3","key":"9413_CR21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ecl.2010.05.003","volume":"39","author":"PE Cryer","year":"2010","unstructured":"Cryer, P. E. (2010). Hypoglycemia in type 1 diabetes mellitus. Endocrinology & Metabolism Clinics of North America, 39(3), 641\u2013654.","journal-title":"Endocrinology & Metabolism Clinics of North America"},{"issue":"7","key":"9413_CR22","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.2337\/db14-0059","volume":"63","author":"PE Cryer","year":"2014","unstructured":"Cryer, P. E. (2014). Glycemic goals in diabetes: Trade-off between glycemic control and iatrogenic hypoglycemia. Diabetes, 63(7), 2188\u20132195.","journal-title":"Diabetes"},{"issue":"6","key":"9413_CR23","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/diacare.26.6.1902","volume":"26","author":"PE Cryer","year":"2003","unstructured":"Cryer, P. E., Davis, S. N., & Shamoon, H. (2003). Hypoglycemia in diabetes. Diabetes Care, 26(6), 1902\u20131912.","journal-title":"Diabetes Care"},{"issue":"2","key":"9413_CR24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1162\/152651601300168834","volume":"1","author":"N Daniels","year":"2001","unstructured":"Daniels, N. (2001). Justice, health, and healthcare. American Journal of Bioethics, 1(2), 2\u201316.","journal-title":"American Journal of Bioethics"},{"key":"9413_CR25","volume-title":"Just health","author":"N Daniels","year":"2008","unstructured":"Daniels, N. (2008). Just health. Cambridge: Cambridge University Press."},{"issue":"9","key":"9413_CR26","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1185\/030079905X61929","volume":"21","author":"RE Davis","year":"2005","unstructured":"Davis, R. E., Morrisey, M., Peters, J. R., Wittrup-Jensen, K., Kennedy-Martin, T., & Currie, C. J. (2005). Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Current Medical Research and Opinion, 21(9), 1477\u20131483.","journal-title":"Current Medical Research and Opinion"},{"issue":"5","key":"9413_CR27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s11892-013-0398-4","volume":"13","author":"D DeSalvo","year":"2013","unstructured":"DeSalvo, D., & Buckingham, B. (2013). Continuous glucose monitoring: Current use and future directions. Current Diabetes Reports, 13(5), 657\u2013662.","journal-title":"Current Diabetes Reports"},{"issue":"3","key":"9413_CR28","first-page":"1","volume":"8","author":"S De Groot","year":"2018","unstructured":"De Groot, S., Enters-Weijnen, C. F., Geelhoed-Duijvestijn, P. H., & Kanters, T. A. (2018). A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands. British Medical Journal Open, 8(3), 1\u201310.","journal-title":"British Medical Journal Open"},{"key":"9413_CR29","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","volume":"353","author":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group","year":"2005","unstructured":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group. (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine, 353, 2643\u20132653.","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"9413_CR30","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2337\/dc16-0207","volume":"39","author":"NC Foster","year":"2016","unstructured":"Foster, N. C., Miller, K. M., Tamborlane, W. V., Bergenstal, R. M., & Beck, R. W. (2016). Continuous glucose monitoring in patients with type 1 diabetes using insulin injections. Diabetes Care, 39(6), e81\u2013e82.","journal-title":"Diabetes Care"},{"key":"9413_CR31","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780198237907.001.0001","volume-title":"Epistemic injustice: Power and the ethics of knowing","author":"M Fricker","year":"2007","unstructured":"Fricker, M. (2007). Epistemic injustice: Power and the ethics of knowing. Oxford: Oxford University Press."},{"issue":"4","key":"9413_CR32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/edrv-12-4-356","volume":"12","author":"JE Gerich","year":"1991","unstructured":"Gerich, J. E., Mokan, M., Veneman, T., Korytkowski, M., & Mitrakou, A. (1991). Hypoglycemic unawareness. Endocrine Reviews, 12(4), 356\u2013371.","journal-title":"Endocrine Reviews"},{"issue":"5","key":"9413_CR33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/jme.29.5.307","volume":"29","author":"R Gillon","year":"2003","unstructured":"Gillon, R. (2003). Ethics needs principles\u2014four can encompass the rest\u2014and respect for autonomy should be 'first among equals'. Journal of Medical Ethics, 29(5), 307\u2013312.","journal-title":"Journal of Medical Ethics"},{"issue":"2","key":"9413_CR34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11019-011-9322-3","volume":"14","author":"B Gordijn","year":"2011","unstructured":"Gordijn, B., & Ten Have, H. (2011). Prioritisation in healthcare\u2014Still muddling through. Medicine, Health Care and Philosophy, 14(2), 109\u2013110.","journal-title":"Medicine, Health Care and Philosophy"},{"issue":"4","key":"9413_CR35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jpeds.2006.05.039","volume":"149","author":"K Hassan","year":"2006","unstructured":"Hassan, K., Loar, R., Anderson, B. J., & Heptulla, R. (2006). The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus. The Journal of Pediatrics, 149(4), 526\u2013531.","journal-title":"The Journal of Pediatrics"},{"issue":"3","key":"9413_CR36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/phe\/phy020","volume":"11","author":"B Haverkamp","year":"2018","unstructured":"Haverkamp, B., Verweij, M., & Stronks, K. (2018). Why socio-economic inequalities in health threaten relational justice: A proposal for an instrumental evaluation. Public Health Ethics, 11(3), 311\u2013324.","journal-title":"Public Health Ethics"},{"issue":"5","key":"9413_CR37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00125-007-0643-y","volume":"50","author":"N Hermanns","year":"2007","unstructured":"Hermanns, N., Scheff, C., Kulzer, B., Weyers, P., Pauli, P., Kubiak, T., et al. (2007). Association of glucose levels and glucose variability with mood in type 1 diabetic patients. Diabetologia, 50(5), 930\u2013933.","journal-title":"Diabetologia"},{"key":"9413_CR38","volume-title":"Role of Continuous Glucose Monitoring in Diabetes Treatment","author":"IB Hirsch","year":"2018","unstructured":"Hirsch, I. B. (2018). Introduction: History of glucose monitoring. In\u00a0Role of Continuous Glucose Monitoring in Diabetes Treatment. Arlington, VA: American Diabetes Association."},{"key":"9413_CR39","doi-asserted-by":"crossref","unstructured":"Hommel, E., Olsen, B., Battelino, T., Conget, I., Sch\u00fctz-Fuhrmann, I., Hoogma, R., Schierloh, U., Sulli, N., Gough, H., Casta\u00f1eda, J., De Portu, S., Bolinder, J., & The SWITCH Study Group. (2014). Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: Analyses from the SWITCH study. Acta Diabetologica, 51(5), 845-851.","DOI":"10.1007\/s00592-014-0598-7"},{"key":"9413_CR40","doi-asserted-by":"crossref","unstructured":"Huang, E. S., O'Grady, M., Basu, A., Winn, A., John, P., Lee, J., Meltzer, D., Kollman, C., Laffel, L., Tamborlane, W., Weinzimer, S., Wysocki, T., & The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2010). The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care, 33(6), 1269-1274.","DOI":"10.2337\/dc09-2042"},{"issue":"10","key":"9413_CR41","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.2337\/dc07-0499","volume":"30","author":"ES Huang","year":"2007","unstructured":"Huang, E. S., Brown, S. E., Ewigman, B. G., Foley, E. C., & Meltzer, D. O. (2007). Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care, 30(10), 2478\u20132483.","journal-title":"Diabetes Care"},{"key":"9413_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.d4163","volume":"343","author":"M Huber","year":"2011","unstructured":"Huber, M., Knottnerus, J. A., Green, L., Van der Horst, H., Jadad, A. R., Kromhout, D., et al. (2011). How should we define health? BMJ, 343, 1\u20133.","journal-title":"BMJ"},{"issue":"7","key":"9413_CR43","first-page":"1","volume":"8","author":"JPA Ioannidis","year":"2011","unstructured":"Ioannidis, J. P. A., & Garber, A. M. (2011). Individualized cost-effectiveness analysis. PLoS Medicine, 8(7), 1\u20136.","journal-title":"PLoS Medicine"},{"issue":"2","key":"9413_CR44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.diabres.2014.12.002","volume":"107","author":"LM Jaacks","year":"2015","unstructured":"Jaacks, L. M., Liu, W., Ji, L., & Mayer-Davis, E. J. (2015). Type 1 diabetes stigma in China: A call to end the devaluation of individuals living with a manageable chronic disease. Diabetes Research and Clinical Practice, 107(2), 306\u2013307.","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"5","key":"9413_CR45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/1049732308316346","volume":"18","author":"B Ingadottir","year":"2008","unstructured":"Ingadottir, B., & Halldorsdottir, S. (2008). To discipline a 'dog': The essential structure of mastering diabetes. Qualitative Health Research, 18(5), 606\u2013619.","journal-title":"Qualitative Health Research"},{"key":"9413_CR46","unstructured":"International Diabetes Federation (IDF). (2017). IDF Diabetes Atlas. 8th edition. Brussels: International Diabetes Federation. https:\/\/www.diabetesatlas.org. Accessed 16 May 2020."},{"issue":"6","key":"9413_CR47","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4158\/EP.10.6.502","volume":"10","author":"AM Jacobson","year":"2004","unstructured":"Jacobson, A. M. (2004). Impact of improved glycemic control on quality of life in patients with diabetes. Endocrine Practice, 10(6), 502\u2013508.","journal-title":"Endocrine Practice"},{"issue":"3","key":"9413_CR48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/dia.2018.0328","volume":"21","author":"J Jendle","year":"2019","unstructured":"Jendle, J., P\u00f6hlmann, J., De Portu, S., Smith-Palmer, J., & Roze, S. (2019). Cost-effectiveness analysis of the MiniMed 670G hybrid closed-loop system versus continuous subcutaneous insulin infusion for treatment of type 1 diabetes. Diabetes Technology & Therapeutics, 21(3), 110\u2013118.","journal-title":"Diabetes Technology & Therapeutics"},{"issue":"1","key":"9413_CR49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcd.2013.09.002","volume":"8","author":"C Kenny","year":"2014","unstructured":"Kenny, C. (2014). When hypoglycemia is not obvious: Diagnosing and treating under-recognized and undisclosed hypoglycemia. Primary Diabetes Care, 8(1), 3\u201311.","journal-title":"Primary Diabetes Care"},{"issue":"2","key":"9413_CR50","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/japp.12172","volume":"34","author":"IJ Kidd","year":"2017","unstructured":"Kidd, I. J., & Carel, H. (2017). Epistemic injustice and illness. Journal of Applied Philosophy, 34(2), 172\u2013190.","journal-title":"Journal of Applied Philosophy"},{"key":"9413_CR51","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780198766452.001.0001","volume-title":"Type 1 diabetes","author":"D Levy","year":"2016","unstructured":"Levy, D. (2016). Type 1 diabetes (2nd ed.). Oxford: Oxford University Press.","edition":"2"},{"key":"9413_CR52","unstructured":"Lispector, C. (2012). Near to the wild heart. A. Entrekin (Trans.). New York: New Directions.\u00a0"},{"issue":"1","key":"9413_CR53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2337\/cd16-0020","volume":"35","author":"NF Liu","year":"2017","unstructured":"Liu, N. F., Brown, A. S., Folias, A. E., Younge, M. F., Guzman, S. J., Close, K. L., et al. (2017). Stigma in people with type 1 or type 2 diabetes. Clinical Diabetes, 35(1), 27\u201334.","journal-title":"Clinical Diabetes"},{"key":"9413_CR54","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2337\/diacare.23.7.934","volume":"23","author":"PJ Lustman","year":"2000","unstructured":"Lustman, P. J., Anderson, R. J., Freeland, K. E., De Groot, M., Carney, R. M., & Clouse, R. E. (2000). Depression and poor glycemic control. Diabetes Care, 23, 934\u2013942.","journal-title":"Diabetes Care"},{"issue":"1","key":"9413_CR55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jdiacomp.2015.09.003","volume":"30","author":"P Martyn-Nemeth","year":"2015","unstructured":"Martyn-Nemeth, P., Farabi, P. S., Mihailescu, D., Nemeth, J., & Quinn, L. (2015). Fear of hypoglycemia in adults with type 1 diabetes: Impact of therapeutic advances and strategies for prevention\u2014A review. Journal of Diabetes and Its Complications, 30(1), 167\u2013177.","journal-title":"Journal of Diabetes and Its Complications"},{"issue":"4","key":"9413_CR56","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11019-012-9454-0","volume":"16","author":"R Mayes","year":"2013","unstructured":"Mayes, R., & Armistead, B. (2013). Chronic disease, prevention policy, and the future of public health and primary care. Medicine, Health Care and Philosophy, 16(4), 691\u2013697.","journal-title":"Medicine, Health Care and Philosophy"},{"key":"9413_CR57","doi-asserted-by":"crossref","first-page":"i5247","DOI":"10.1136\/bmj.i5247","volume":"354","author":"M McCarthy","year":"2016","unstructured":"McCarthy, M. (2016). Doctors recommend continuous glucose monitoring for patients with type 1 diabetes. BMJ, 354, i5247.","journal-title":"BMJ"},{"issue":"9","key":"9413_CR58","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2337\/dc11-2054","volume":"35","author":"RG McCoy","year":"2012","unstructured":"McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A. (2012). Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care, 35(9), 1897\u20131901.","journal-title":"Diabetes Care"},{"issue":"13","key":"9413_CR59","first-page":"1","volume":"9","author":"RB McQueen","year":"2011","unstructured":"McQueen, R. B., Ellis, S. L., Campbell, J. D., Nair, K. V., & Sullivan, P. W. (2011). Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes. Cost Effectiveness and Resource Allocation, 9(13), 1\u20138.","journal-title":"Cost Effectiveness and Resource Allocation"},{"issue":"2","key":"9413_CR60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s13300-019-0576-8","volume":"10","author":"IA Mohamed","year":"2019","unstructured":"Mohamed, I. A., Fisher, A., Cooper, P., & Hussain, S. (2019). Use of continuous glucose monitoring in people with type 1 diabetes: Perspectives of two people with diabetes and physician perspective. Diabetes Therapy, 10(2), 333\u2013340.","journal-title":"Diabetes Therapy"},{"issue":"2","key":"9413_CR61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/15265160802654111","volume":"9","author":"AD Naik","year":"2009","unstructured":"Naik, A. D., Dyer, C. B., Kunik, M. E., & McCullough, L. B. (2009). Patient autonomy for the management of chronic conditions: A two-component re-conceptualization. The American Journal of Bioethics, 9(2), 23\u201330.","journal-title":"The American Journal of Bioethics"},{"key":"9413_CR62","unstructured":"Neinstein, A. (2019). By 2025, a lot more people will be tracking their blood sugar, predicts doctor\u2014Here's why. CBNC Health Tech Matters. https:\/\/www.cnbc.com\/2019\/01\/31\/blood-sugar-tracking-useful-for-more-than-diabetes-commentary.html. Accessed 16 May 2020."},{"key":"9413_CR200","unstructured":"Netherlands National Institute for Public Health and the Environment. (2020a). Ranglijst aandoeningen op basis van ziektelast (in DALY's). https:\/\/www.volksgezondheidenzorg.info\/ranglijst\/ranglijst-aandoeningen-op-basis-van-ziektelast-dalys. Accessed 16 May 2020."},{"key":"9413_CR201","unstructured":"Netherlands National Institute for Public Health and the Environment. (2020b). Toelichting op de data. http:\/\/volksgezondheidenzorg.info\/sites\/default\/files\/20180528_data_ziektelast_2015.ods. Accessed 16 May 2020."},{"issue":"2","key":"9413_CR63","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1464-5491.2004.01370.x","volume":"22","author":"EA Northam","year":"2004","unstructured":"Northam, E. A., Matthews, L. K., Anderson, P. J., Cameron, F. J., & Werther, G. A. (2004). Psychiatric morbidity and health outcome in type 1 diabetes\u2014Perspectives from a prospective longitudinal study. Diabetic Medicine, 22(2), 152\u2013157.","journal-title":"Diabetic Medicine"},{"key":"9413_CR202","unstructured":"OANDA. (2020). Currency converter. https:\/\/www1.oanda.com\/currency\/converter\/. Accessed 16 May 2020."},{"issue":"3","key":"9413_CR64","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","volume":"62","author":"CC Patterson","year":"2019","unstructured":"Patterson, C. C., Harjutsalo, V., Rosenbauer, J., Neu, A., Cinek, O., Skrivarhaug, T., et al. (2019). Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989\u20132013: A multicenter prospective registration study. Diabetologia, 62(3), 408\u2013417.","journal-title":"Diabetologia"},{"issue":"11","key":"9413_CR65","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2016-2534","volume":"101","author":"AL Peters","year":"2016","unstructured":"Peters, A. L., Ahmann, A. J., Battelino, T., Evert, A., Hirsch, I. B., Murad, M. H., et al. (2016). Diabetes technology\u2014Continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 101(11), 3922\u20133937.","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"9413_CR66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4324\/9781315212043-2","volume-title":"The Routledge handbook of epistemic injustice","author":"G Pohlhaus","year":"2017","unstructured":"Pohlhaus, G. (2017). Varieties of epistemic injustice. In\u00a0 J. Kidd, J. Medina, & G. Pohihaus, Jr. (Eds.)\u00a0The Routledge handbook of epistemic injustice (pp. 13\u201326). New York: Routledge."},{"issue":"3","key":"9413_CR67","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/1049732306298631","volume":"17","author":"B Rasmussen","year":"2007","unstructured":"Rasmussen, B., O'Connell, B., Dunning, P., & Cox, H. (2007). Young women with type 1 diabetes' management of turning points and transitions. Qualitative Health Research, 17(3), 300\u2013310.","journal-title":"Qualitative Health Research"},{"issue":"4","key":"9413_CR68","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/dme.13561","volume":"35","author":"M Reddy","year":"2018","unstructured":"Reddy, M., Jugnee, N., El Laboudi, A., Spanudakis, E., Anatharaja, S., & Oliver, N. (2018). A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia. Diabetic Medicine, 35(4), 483\u2013490.","journal-title":"Diabetic Medicine"},{"issue":"4","key":"9413_CR69","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1191\/0969733005ne801oa","volume":"12","author":"BK Redman","year":"2005","unstructured":"Redman, B. K. (2005). The ethics of self-management preparation for chronic illness. Nursing Ethics, 12(4), 360\u2013369.","journal-title":"Nursing Ethics"},{"issue":"s3","key":"9413_CR70","doi-asserted-by":"crossref","first-page":"s25","DOI":"10.1089\/dia.2017.0035","volume":"19","author":"D Rodbard","year":"2017","unstructured":"Rodbard, D. (2017). Continuous glucose monitoring: A review of recent studies demonstrating improved glycemic outcomes. Diabetes Technology & Therapeutics, 19(s3), s25\u2013s37.","journal-title":"Diabetes Technology & Therapeutics"},{"issue":"3","key":"9413_CR71","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3111\/13696998.2015.1113979","volume":"19","author":"S Roze","year":"2016","unstructured":"Roze, S., Smith-Palmer, J., Valentine, W. J., Cook, M., Jethwa, M., De Portu, S., et al. (2016). Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: A UK perspective. Journal of Medical Economics, 19(3), 236\u2013242.","journal-title":"Journal of Medical Economics"},{"issue":"1","key":"9413_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40271-012-0001-0","volume":"6","author":"J Schabert","year":"2013","unstructured":"Schabert, J., Browne, J. L., Mosely, K., & Speight, J. (2013). Social stigma in diabetes: A framework to understand a growing problem for an increasing epidemic. The Patient - Patient-Centered Outcomes Research, 6(1), 1\u201310.","journal-title":"The Patient - Patient-Centered Outcomes Research"},{"key":"9413_CR73","unstructured":"Schlosser, M. (2015). Agency. In E. N. Zalta (Ed.), The Stanford encyclopedia of philosophy. https:\/\/plato.stanford.edu\/archives\/fall2015\/entries\/agency. Accessed 16 May 2020."},{"issue":"8","key":"9413_CR74","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jdiacomp.2017.05.009","volume":"31","author":"CB Schmidt","year":"2017","unstructured":"Schmidt, C. B. (2017). Validation of a quick screening instrument for measuring fear of hypoglycaemia in persons with diabetes. Journal of Diabetes and Its Complications, 31(8), 1360\u20131361.","journal-title":"Journal of Diabetes and Its Complications"},{"issue":"9","key":"9413_CR75","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1365-2702.2008.02729.x","volume":"18","author":"VD Sousa","year":"2008","unstructured":"Sousa, V. D., Hartman, S. W., Miller, E. H., & Carroll, M. A. (2008). New measures of diabetes self-care agency, diabetes self-efficacy, and diabetes self-management for insulin-treated individuals with type 2 diabetes. Journal of Clinical Nursing, 18(9), 1305\u20131312.","journal-title":"Journal of Clinical Nursing"},{"issue":"9","key":"9413_CR76","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1089\/dia.2016.0171","volume":"18","author":"J \u0160oupal","year":"2016","unstructured":"\u0160oupal, J., Petru\u017eelkov\u00e1, L., Fleka\u010d, M., Pelcl, T., Matoulek, M., Da\u0148kov\u00e1, M., et al. (2016). Comparison of different treatment modalities for type 1 diabetes, including sensor-augmented insulin regimens, in 52 weeks of follow-up: A COMISAIR study. Diabetes Technology & Therapeutics, 18(9), 532\u2013538.","journal-title":"Diabetes Technology & Therapeutics."},{"key":"9413_CR77","unstructured":"Standl, E. (2019). Global statistics on diabetes. European Association of Preventive Cardiology.\u00a0https:\/\/www.escardio.org\/Sub-specialty-communities\/European-Association-of-Preventive-Cardiology-(EAPC)\/News\/global-statistics-on-diabetes. Accessed 16 May 2020."},{"key":"9413_CR78","unstructured":"Trading Economics. (2019). Netherlands gross monthly income. https:\/\/tradingeconomics.com\/netherlands\/wages. Accessed 16 May 2020."},{"issue":"6","key":"9413_CR79","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2174\/1573399810666141113115026","volume":"10","author":"M Vallis","year":"2014","unstructured":"Vallis, M., Jones, A., & Pouwer, F. (2014). Managing hypoglycemia in diabetes may be more fear management than glucose management: A practical guide for diabetes care providers. Current Diabetes Reviews, 10(6), 364\u2013370.","journal-title":"Current Diabetes Reviews"},{"issue":"7","key":"9413_CR80","doi-asserted-by":"crossref","first-page":"A292","DOI":"10.1016\/S1098-3015(11)72105-2","volume":"13","author":"ML VanGenugten","year":"2010","unstructured":"VanGenugten, M. L. (2010). PDB47 the cost-effectiveness of continuous glucose monitoring in type 1 diabetes patients in the Netherlands. Value in Health, 13(7), A292.","journal-title":"Value in Health"},{"key":"9413_CR81","volume-title":"Health justice","author":"S Venkatapuram","year":"2011","unstructured":"Venkatapuram, S. (2011). Health justice. Cambridge: Polity Press."},{"issue":"6","key":"9413_CR82","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2337\/dc17-1821","volume":"41","author":"W Wan","year":"2018","unstructured":"Wan, W., Skandari, M. R., Minc, A., Nathan, A. G., Winn, A., Zarei, P., et al. (2018). Cost-effectiveness of continuous glucose monitoring for adults with type 1 diabetes compared with self-monitoring of blood glucose: The DIAMOND randomized trial. Diabetes Care, 41(6), 1227\u20131234. https:\/\/doi.org\/10.2337\/dc17-1821.","journal-title":"Diabetes Care"},{"issue":"Suppl. 2","key":"9413_CR83","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/imj.13770","volume":"48","author":"A Wood","year":"2018","unstructured":"Wood, A., O'Neal, D., Furler, J., & Ekinci, E. I. (2018). Continuous glucose monitoring: A review of the evidence, opportunities for future use and ongoing challenges. Internal Medicine Journal, 48(Suppl. 2), 499\u2013508.","journal-title":"Internal Medicine Journal"},{"issue":"1","key":"9413_CR84","first-page":"1","volume":"4","author":"W-P You","year":"2015","unstructured":"You, W.-P., & Henneberg, M. (2015). Type 1 diabetes prevalence increasing globally and regionally: The role of natural selection and life expectancy at birth. BMJ Open Diabetes Research and Care, 4(1), 1\u20137.","journal-title":"BMJ Open Diabetes Research and Care"},{"key":"9413_CR85","unstructured":"Zorginstituut Nederland. (2018). Ziektelast in de Praktijk: De theorie en praktijk van het berekenen van ziektelast bij pakketbeoordelingen. https:\/\/www.zorginstituutnederland.nl\/binaries\/zinl\/documenten\/rapport\/2018\/05\/07\/ziektelast-in-de-praktijk\/Ziektelast+in+de+praktijk_definitief.pdf. Accessed 16 May 2020."}],"container-title":["HEC Forum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10730-020-09413-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10730-020-09413-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10730-020-09413-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T12:12:54Z","timestamp":1636632774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10730-020-09413-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["9413"],"URL":"https:\/\/doi.org\/10.1007\/s10730-020-09413-9","relation":{},"ISSN":["0956-2737","1572-8498"],"issn-type":[{"value":"0956-2737","type":"print"},{"value":"1572-8498","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]},"assertion":[{"value":"21 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}